The b-chain of the high-affinity receptor for IgE (FceRI) plays a crucial role for amplification of the intracellular signaling in mast cells upon FceRI cross-linking by IgEantigen complexes (IgEAg). Some monomeric IgE as well as IgEAg stimulate FceRI-signaling pathways, leading to cell activation, whereas the biological functions of the b-chain in the monomeric IgE-mediated mast cell signaling and responses are largely unknown. In the present study, FceRI is reconstituted with either wild-type b-chain or mutated b-chain immunoreceptor tyrosine-based activation motif (ITAM) employing retrovirus-mediated gene transfer into the FceRI b-chainÿ/ÿ mast cells. We demonstrated that the transfectants with mutated b-chain ITAM stimulated with monomeric IgE sufficiently produce inflammatory cytokines, although degranulation, intracellular Ca 21 mobilization and leukotriene C 4 synthesis are significantly reduced. Furthermore, analyses of molecular mechanisms of the signaling revealed that the expression of cytokine genes and activation of extracellular signal-regulated kinase 1/2 and protein kinase C were significantly delayed in the b-chain ITAM mutant cells stimulated with monomeric IgE, suggesting that the b-chain ITAM regulates kinetics of gene transcriptions and signaling pathways for cytokine production. These findings for the first time revealed the unique functions of the b-chain ITAM in both chemical mediator release and cytokine production of mast cells upon monomeric IgE stimulation.
Introduction
Mast cells express the high-affinity receptor for IgE (FceRI) on the cell surface, which plays a central role in the development of allergic inflammation. Aggregation of the FceRI on mast cells by bound IgE and multivalent antigens induces release of inflammatory mediators from the granules and production of inflammatory cytokines (1) .
FceRI is mainly expressed on mast cells and basophils as a tetramer of a-, b-and c-chain homodimers (2) . The a-chain binds IgE, while b-and c-chains mediate intracellular signaling through immunoreceptor tyrosine-based activation motif (ITAM) in their cytoplasmic domains. The b-chain has been revealed to play an important role for amplifying the c-chainmediated intracellular signals through enhancing Syk kinase activation and/or a-chain maturation (3) (4) (5) (6) . In general, FceRI cross-linking by IgEantigen complexes (IgEAg) is believed to cause tyrosine phosphorylation of the b-chain ITAM via activated Lyn, and subsequent phosphorylation of c-chain ITAM and Syk, which then leads to activation of downstream signals such as intracellular Ca 2+ mobilization, and activation of protein kinase C (PKC) and mitogen-activated protein kinase (MAPK) family (7, 8) . Thus, tyrosine phosphorylation of the b-chain ITAM is a crucial event for initiation of a series of responses in mast cell activation. In addition, the b-chain ITAM possesses a non-canonical tyrosine residue between the canonical two-tyrosine residues in the C-terminal intracellular portion, although ITAM of the c-chain and other receptors have only the canonical two-tyrosine residues. We have recently shown that phosphorylation of the non-canonical tyrosine residue of the b-chain ITAM mediates suppressive signals for cytokine production upon IgEAg stimulation (9) . Therefore, it is likely that physiological functions of the b-chain ITAM in mast cells are cleverly regulated by phosphorylation of noncanonical and canonical tyrosine residues. Previous reports revealed that binding of monomeric IgE to the FceRI enhances mast cell survival (10, 11) and surface expression of FceRI (12) . Recently, these monomeric IgEs have been divided into two categories, highly cytokinergic and poor cytokinergic IgEs. The highly cytokinergic IgEs, e.g. SPE7 and H1-e-26, can elicit not only the production and secretion of various cytokines but also other activation events, including receptor internalization, degranulation and histamine synthesis (13) (14) (15) (16) .
For these responses induced by IgE loading, activation of the c-chain ITAM is crucial and loss of its function results in suppression of monomeric IgE-mediated IL-6 production and cell survival (17) . However, little is known about the biological significance and functions of the b-chain ITAM in mast cell activation with the monomeric IgE stimulation. In the present study, we investigated the biological roles of the b-chain ITAM in the monomeric IgE-mediated mast cell activation employing the b-chain ITAM mutant, in which canonical and noncanonical tyrosine residues are replaced with phenylalanine. We demonstrated that normal tyrosine phosphorylation of the wild-type b-chain ITAM is indispensable for the monomeric IgE-mediated degranulation, leukotriene (LT) C 4 secretion and Ca 2+ influx and that it contributes to initiation of cytokine gene transcription, activation of PKC and extracellular signalregulated kinase (ERK) 1/2 in vitro. This is the first report that revealed functions of the b-chain ITAM in mast cell activation upon monomeric IgE stimulation.
Methods

Reagents
Anti-b-chain mAb [clone JRK: the hybridoma (JRK) was kindly gifted by Juan Rivera at National Institutes Health (NIH), USA] was prepared in our laboratory. Anti-trinitrophenol (TNP) IgE (clone IgE3) was purchased from Pharmingen (San Diego, CA, USA) and was labeled with FITC. Anti-dinitrophenyl (DNP) IgE (clone SPE7) was purchased from Sigma (St Louis, MO, USA). Anti-DNP H1-e-26 was purified as described previously (18) . DNP BSA was purchased from LSL (Tokyo, Japan). Recombinant stem cell factor (SCF) was kindly gifted from Kirin Brewery Co. (Tokyo, Japan). Polyclonal antibody to Lyn was purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). All anti-phospho-specific, anti-ERK1/2, anti-Akt antibodies and wortmannin were purchased from Cell Signaling Technology (Beverly, MA, USA).
Mice
FceRI b-chainÿ/ÿ mice (5) were bred in the animal faculty at Nihon University School of Medicine under specific pathogenfree conditions. All experiments were performed according to the guidelines of Nihon University.
Cell culture
Bone marrow-derived mast cells (BMMCs) were prepared from the femur of 4-to 8-week old b-chainÿ/ÿ mice as described previously (19) . Cells were cultured in the RPMI 1640 (Sigma) supplemented with 20% FBS (Sigma) and 5 ng ml ÿ1 of murine recombinant IL-3. BMMCs were used for experiments after 4-8 weeks of culture. For retroviral transfection, bone marrow cells were cultured in the presence of 100 ng ml ÿ1 SCF for another 1 week. An ecotropic retrovirus packaging cell line, Platinum-E (PLAT-E) (kindly gifted by Toshio Kitamura at Tokyo University, Japan) was maintained in DMEM supplemented with 10% FBS, 1 lg ml ÿ1 puromycin (Clontech, San Jose, CA, USA) and 10 lg ml ÿ1 blasticidin S (Kaken Pharmaceutical Co., Tokyo, Japan).
cDNA constructions and transfections
The mouse b-chain cDNA was constructed as previously described (19) . Phenylalanine substitutions for tyrosine of bchain ITAM (Y210F/Y216F/Y220F) was generated by using a PCR-based, site-directed mutagenesis kit (Stratagene, La Jolla, CA, USA). Mutation of b-chain was confirmed by DNA sequencing. Then, b-chain cDNAs were subcloned into the EcoRI site of the retroviral vector pMx-puro (20) . These plasmids were transfected into PLAT-E packaging cells with Fugene 6 (Roche Diagnostics, Basel, Switzerland) to generate retroviruses. BMMCs (5 3 10 6 ) were infected with the retroviruses for 48 h in the presence of 1 lg ml ÿ1 polybrane (Sigma). For the preparation of b-chain ITAM transfectants, gene-transduced cells were selected with 1.2 lg ml ÿ1 puromycin for 7 days. Viable cells (10-20% of BMMCs cultured with retroviruses) were expanded for several weeks before experiments. Wild-type and mutated b-chain ITAM transfectants were named YYY wild-type and FFF mutant, respectively.
Immunoblotting
The stimulated cells were washed twice with ice-cold PBS and lysed in Tris-buffered saline containing 1% NP-40, 60 mM octyl-b-glucoside, 2 mM phenylmethylsulphonylfluoride, 10 lg ml ÿ1 aprotinin, 2 lg ml ÿ1 leupeptin and pepstatin A, 50 mM NaF and 1 mM sodium orthovanadate, for 30 min on ice as previously described (21) . The lysates were centrifuged for 15 min at 14 000 3 g. For immunoprecipitation, the cell lysates were incubated with antibody-bound-protein A sepharose for 3 h on ice. The immunoprecipitates were resuspended in an equal volume of 23 Laemmli buffer. The samples were then boiled, separated on 10 or 12% SDS-PAGE and transferred on to Immobilon-P membrane (Millipore, Bedford, MA, USA). The membrane was incubated with primary antibody and an appropriate secondary HRP-conjugated antibody. Signals were detected by enhanced chemiluminescence (Amersham Bioscience, Little Chalfont, United Kingdom). The immunoreactive bands were scanned to produce digital images that were quantified employing NIH Image software (http:// rsb.info.nih.gov/nih-image), and then kinase activation was calculated by the relative amount of phospho-ERK1/2, phospho-c-Jun N-terminal kinase (JNK) 1/2 protein to each non-phospho protein.
b-hexosaminidase release assay
Degranulation of mast cells was determined by b-hexosaminidase release as described previously (19) . Briefly, cells (5 3 10 5 ) were stimulated in 0.2 ml 13 Tyrode's buffer at indicated concentrations of monomeric IgEs or antigen at 37°C for 30 min. The cells were lysed with 1% NP-40 in the above-mentioned medium. The supernatants and the total cell lysates were incubated with 1.3 mg ml ÿ1 of p-nitrophenyl-Nacetyl-b-D-gulcopyranoside (Sigma) in 0.1 M sodium citrate buffer (pH 4.5) at 37°C for 40 min. The reaction was terminated by the addition of 0.2 M glycine buffer (pH 10.7). The release of the product 4-p-nitrophenol was evaluated by optical absorbance at 405 nm.
Measurements of cytokines and LTC 4
Cell culture supernatants after FceRI stimulation were analyzed for IL-6, IL-13, tumor necrosis factor-a (TNF-a) and LTC 4 production by specific ELISA kits [Cayman Chemical (Ann Arbor, MI, USA) for LTC 4 , Endogen (Rockford, IL, USA) for IL-6, IL-13 and TNF-a] according to the manufacture's instructions. In experiments using a phosphatidylinositol 3-kinase (PI3K) inhibitor, cells were pre-treated with 0.5 lM of wortmannin for 30 min at 37°C.
Flow cytometry
For the evaluation of FceRI expression on the cell surface, cells (5 3 10 5 ) were stained with 1 lg ml ÿ1 FITC-conjugated anti-TNP IgE at 4°C for 30 min and then washed twice with PBS containing 0.1% sodium azide. The stained cells were analyzed with FACSCalibur (Becton-Dickinson, San Jose, CA, USA). b-Chainÿ/ÿ BMMCs were used as negative controls. The receptor internalization was defined as the difference of FceRI expression on the cell surface in mean fluorescence intensity ratio (before/after FceRI stimulation).
Reverse transcription-PCR
Total RNA was isolated from BMMCs using ISOGEN (Nippon Gene, Tokyo, Japan). cDNA was reverse transcribed from 2 lg ml ÿ1 total RNA by 200 U of Superscripts II, 2.5 mM dNTP and 1.0 mM oligo (dT) primer. The resultant cDNA was then employed as templates for the PCR. The open reading frames of IL-6, IL-13, TNF-a and b-actin were amplified using appropriate primers as follows: 59-ATGAAGTTCCTCTCTG-CAAG-39 and 59-GTACTCCAGGTAGCTATGGT-39 (IL-6); 59-ATGGCGCTCTGGGTGACTGC-39 and 59-ATGGTCTCTCCT-CATTAGAA-39 (IL-13); 59-ATGAGCACAGAAAGCATGAT-39 and 59-GAACCTGGGAGTAGACAAGG-39 (TNF-a) and 59-ATGGATGACGATACGCTGC-39 and 59-CCATCACAATGCCT-GTGGTA-39 (b-actin). PCR was performed in the conditions as follows, denaturation at 94°C for 30 s, annealing at 60°C for 1 min and extension at 72°C for 2 min with 27 cycles, and then a 10 min elongation at 72°C). The PCR products were applied on to a 1% agarose gel and visualized by ethidium bromide staining. Data were quantified employing NIH Image software, and the fold induction was calculated by the relative amount of cytokine mRNA to b-actin mRNA (internal control). 
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Statistical analysis
Student's t-test was performed to determine statistical significance among the experimental groups; P < 0.05 was considered significant.
Results
b-chain ITAM is indispensable for mediator release of mast cells stimulated with the monomeric IgE
Before analyses for functions of the b-chain ITAM, we confirmed expression of the reconstituted FceRI in the b-chain transfectants using flow cytometry. Fig. 1 (A) displays construction of the substituted b-chain ITAM. As shown in Fig.  1(B) , FceRI expression was at almost same levels in the YYY wild-type cells and the FFF mutant cells, and BMMCs of bchainÿ/ÿ mice expressed no FceRI on the cell surface. These results are consistent with our recent study in which mutation of b-chain ITAM had no effects on FceRI expression on the cell surface (9) .
To clarify biological functions of the b-chain ITAM for inflammatory mediator release of mast cells, we first examined b-hexosaminidase (one of the intragranullar enzymes) release from the monomeric IgE-stimulated (SPE7, H1-e-26) b-chain transfectants ( Fig. 1C and D) . Interestingly, in the monomeric IgE-stimulated FFF mutant cells, b-hexosaminidase release was severely impaired, and no release was observed even when the concentration of the monomeric IgEs was increased to 50 lg ml ÿ1 (data not shown). In contrast to monomeric IgE stimulation, upon IgEAg stimulation, b-hexosaminidase release of the FFF mutant cells was induced to 50% level of the YYY wild-type cells (Fig. 1E) . Next, we evaluated LTC 4 release which is one of the newly generated inflammatory mediators. As expected, LTC 4 secretion as well as b-hexosaminidase release was also impaired in the monomeric IgE-stimulated FFF mutant cells. It is thereby concluded that LTC 4 secretion and degranulation in response to the monomeric IgE require the b-chain ITAM as a critical element.
Since intracellular Ca 2+ is an essential second messenger for chemical mediator release (23, 24) , we evaluated extracellular Ca 2+ influx into these transfectants employing a calcium indicator, Fluo-3AM. As displayed in Fig. 2(B 
Effects of the b-chain ITAM on Lyn recruitment to and internalization of the FceRI
Lyn is known as a major Src kinase in mast cells and is to be activated immediately upon IgEAg stimulation (25) . Activated Lyn then strongly binds to b-chain ITAM, leading to subsequent activation of signaling cascades (26) . Additionally, it was recently reported that Lyn activation and FceRI b-chain phosphorylation in the monomeric IgE-stimulated mast cells were very weak, when compared with those in the IgEAgstimulated mast cells (10, 16) . Therefore, we examined the association between Lyn and the b-chain by co-immunoprecipitation assay upon FceRI stimulation. Western blotting analyses revealed that recruiting of Lyn to the b-chain was almost undetectable in the YYY wild-type and the FFF mutant cells upon the monomeric IgE stimulation (Fig. 3A, left panel) , although it was sufficiently detectable in the YYY wild-type cells stimulated with IgEAg. In the FFF mutant cells, Lyn recruitment to the b-chain was not detected even when the concentration of the antigen was up to 100 ng ml ÿ1 (Fig. 3A , right panel). These findings suggest that the monomeric IgE stimulation in the YYY wild-type and the FFF mutant cells was insufficient for activation of the b-chain ITAM by Lyn and the subsequent signaling cascades. However, it was recently reported that monomeric IgE can induce Lyn-dependent mast cell activation. For instance, FceRI internalization in response to the monomeric IgE loading is severely impaired in Lynÿ/ÿ mast cells (14) . To evaluate the contribution of Lyn-dependent signaling in these transfectants, we examined whether FceRI internalization is induced by monomeric IgE stimulation. As shown in Fig. 3(B) , in the YYY wild-type cells, FceRI internalization was immediately induced upon SPE7 stimulation. On the other hand, in the FFF mutant cells, FceRI internalization was not observed until at the longest 60 min after stimulation. Collectively, these results indicate that the Lyn-dependent signaling pathway is impaired in the monomeric IgE-stimulated FFF mutant cells and that the b-chain ITAM is necessary for signal transduction through Lyn. 
b-chain ITAM regulates transcription of cytokine genes
It was recently reported that monomeric IgE induces inflammatory cytokine production in mast cells (10) . Since chemical mediator release and Lyn-dependent cellular responses were severely reduced in the activated FFF mutant cells stimulated with monomeric IgE, cytokine production was thought to be also defective in the FFF mutant cells. We therefore examined production of IL-6, IL-13 and TNF-a in the transfectants. As shown in Fig. 4(A-C) , cytokine production of the SPE7-stimulated FFF mutant cells was sufficiently induced, but the levels were lower than those of the SPE7-stimulated YYY wild-type cells. In the YYY wild-type cells, H1-e-26 as well as SPE7 also sufficiently induced IL-6 production, while IL-6 production of the H1-e-26-stimulated FFF mutant cells was reduced and delayed (Fig. 4D) . In the FFF mutant cells, significant IL-6 production was induced at 480 min after H1-e-26 stimulation. These results suggest that cytokine gene transcription is delayed in the FFF mutant cells stimulated with monomeric IgE.
We next analyzed expression of IL-6, IL-13 and TNF-a genes employing reverse transcription-PCR (Fig. 5A) , and the results of their densitometric analyses were shown in Fig. 5(B) . It was of interest that expression of IL-6 and IL-13 genes in the SPE7-stimulated FFF mutant cells did not reach maximum levels until 60 min, while expression of these genes in the SPE7-stimulated YYY wild-type cells reached maximum levels within 60 min and decreased thereafter. On the other hand, kinetics of TNF-a gene transcription was delayed in the SPE7-stimulated FFF mutant cells. These results clearly indicate that loss of function of the b-chain ITAM (changes of Y to F) makes a delay in the monomeric IgE-initiated transcription for IL-6, IL-13 and TNF-a genes.
Akt activity is severely impaired in the FFF mutant cells stimulated with the monomeric IgE
As demonstrated in Fig. 5 , cytokine gene expression was obviously delayed in the monomeric IgE-stimulated FFF mutant cells. Since Krystal and colleagues reported that LY294002, one of PI3K inhibitors, significantly suppressed monomeric IgE-induced IL-6 production (10), we examined IL-6 and IL-13 production in the late phase response of the transfectants to the monomeric IgE in the presence or absence of a PI3K inhibitor, wortmannin. A concentration of 0.5 lM wortmannin effectively suppressed IL-6 and IL-13 production in the SPE7-stimulated FFF mutant and YYY wildtype cells (Fig. 6A) . These findings indicate that production of IL-6 and IL-13 may be dependent on PI3K pathway. Since Akt, a member of PI3K cascades, is known to contribute to cytokine production in mast cells (27) , we next examined activation of Akt in the monomeric IgE-stimulated mast cells. Unexpectively, Akt activation was almost undetectable in the SPE7-stimulated FFF mutant cells, while it was clearly detected in the SPE7-stimulated YYY wild-type cells (Fig. 6B) .
Delayed activation of ERK in the FFF mutant cells stimulated with the monomeric IgE
Because specific inhibitors of MAPK family were reported to significantly suppress IL-6 and IL-13 production in activated mast cells (28) (29) (30) , we examined activities of ERK1/2 and JNK1/2 in activated mast cells. As demonstrated in Fig. 6(C) , the prolonged phosphorylation of ERK1/2 and JNK1/2 was observed in both the SPE7-stimulated YYY wild-type and FFF mutant cells. However, it is noteworthy that initiation of ERK1/2 phosphorylation in the SPE7-stimulated FFF mutant cells was significantly delayed, compared with that of the SPE7-stimulated YYY wild-type cells. These findings seem to be in accordance with the results of cytokine production in the monomeric IgE-activated YYY wild-type and FFF mutant cells.
Effects of the b-chain ITAM on SH2 domain containing inositol 59-phosphatase and PKC activation SH2 domain containing inositol 59-phosphatase (SHIP)-1 is known to act as a negative regulator for mast cell activation through FceRI, and its phosphorylation requires activation of Lyn (31) . In SHIP-1ÿ/ÿ mast cells, production of IL-6, IL-13 and TNF-a induced by IgEAg is significantly enhanced through enhanced PKC activation and prolongation of ERK1/2, JNK1/2 and Akt activation (28) . Fig. 3(A and B) suggests that SHIP-1 phosphorylation would be reduced in the monomeric IgE-stimulated FFF mutant cells. We therefore investigated whether SHIP-1 is activated in the b-chain transfectants upon monomeric IgE stimulation. As shown in Fig. 6(D) , SHIP-1 phosphorylation in response to the SPE7 was significantly reduced in the FFF mutant cells. In contrast to the FFF mutant cells, SHIP-1 was obviously phosphorylated at 20 min after the SPE7 stimulation in the YYY wild-type cells, indicating that SHIP-1 activation depends on function of the b-chain ITAM. Based on the previous report using SHIP-1ÿ/ÿ mice, we speculated that activation of PKCs might be characteristically regulated in the FFF mutant cells. To examine this possibility, we employed anti-phospho PKC (pan) antibody, which detects PKC a, bI, bII, d, e, g and h isoforms when homologous regions of serine 660 of PKC bII are phosphorylated. Fig. 6(E) demonstrates that PKC activation in the monomeric IgEstimulated FFF mutant cells was significantly delayed and reduced, suggesting that the kinetics of PKC activation may correlate with IL-6/IL-13 gene expression.
Discussion
Mast cells respond not only to IgEAg but also to some highly cytokinergic IgEs such as SPE7 and H1-e-26 and exert various cellular reactions. However, mechanisms of signal transduction in response to monomeric IgEs are largely unknown.
In this study, we found that upon monomeric IgE stimulation, loss of function of canonical and non-canonical tyrosine residues in the b-chain ITAM leads to impairment of immediate phase responses such as b-hexosaminidase release, intracellular Ca 2+ mobilization and LTC 4 secretion, and delay of gene expression for inflammatory cytokines, ERK1/2 and PKCs phosphorylation. These results suggest that the b-chain ITAM regulates kinetics of gene transcriptions related to cytokine production through modulation of intracellular signaling pathways, although these signalings based on the b-chain ITAM are not sufficient for chemical mediator release of mast cells.
Elevation of intracellular Ca 2+ concentration ([Ca   2+ ] i ) is known as crucial for chemical mediator release (degranulation) of mast cells. Recently, it was reported that intracellular Ca 2+ mobilization in the Lynÿ/ÿ mast cells was significantly reduced upon monomeric IgE stimulation (15) , suggesting that Lyn plays an important role for monomeric IgE-mediated Ca 2+ responses in mast cells. As shown in Fig. 2(B ) were stimulated with SPE7 at indicated concentrations for 30 and 180 min. After incubation, the supernatants were evaluated for IL-6 (A), IL-13 (B) and TNF-a (C) by specific ELISA. Statistical analyses were performed by Student's t-test. *P < 0.05 relative to maximum release of the YYY wild-type transfectants. (D) Cells were stimulated with 10 lg ml ÿ1 of H1-e-26 for 30, 180 and 480 min. After incubation, IL-6 production was measured by specific ELISA. Statistical analyses were performed by Student's t-test. *P < 0.05 relative to IL-6 production of each non-stimulated transfectant.
impaired. In addition to these findings, recruitment of Lyn to the b-chain was actually undetectable upon the monomeric IgE stimulation. Collectively, these results indicate that the FFF mutant cells lack the signaling which evokes [Ca 2+ ] i increase leading to the release of inflammatory mediators in mast cells, which reveals signal regulatory roles of the b-chain ITAM for degranulation.
In this study, it is of note that monomeric IgE-stimulated FFF mutant cells can produce substantial amount of inflammatory cytokines although their intracellular signaling is deficient for chemical mediator release, which suggests that the b-chain ITAM may act as a signal amplifier (for chemical mediator release) or a signal suppressor (for cytokine production) in mast cell activation by monomeric IgE stimulation. Regarding cytokine production induced by monomeric IgE stimulation, one of the crucial roles of the b-chain ITAM is regulation of the kinetics for cytokine gene expression. As shown in Fig. 5(A) , in the monomeric IgE-stimulated FFF mutant cells, transcription of IL-6 and IL-13 genes was obviously delayed and their production was considerably suppressed by wortmannin, which inhibits PI3K pathway including Akt (Fig. 6A) . However, inhibitory effects of wortmannin were not correlated with Akt activities in mast cells. Since wortmannin broadly inhibits class I PI3K, class II PI3K-C2a, 2b and 2c, class III PI3K and class IV PI3K activity (32) , even if this compound affects a PI3K activity in the process of cytokine synthesis, it will be difficult to dissect the involvement of individual PI3K members. In addition, the roles of individual PI3K isoforms in Akt activation are largely unknown, although Akt is one of the downstream molecules of PI3K cascades. These findings may suggest that cytokine production of the monomeric IgE-stimulated FFF mutant cells may be regulated by other PI3K signalings, except PI3K-Akt pathway. Alternatively, this discrepancy might be explained by other pharmacological actions of wortmannin such as suppression of translational process through inhibition of p70 S6 kinase activation (33, 34) . Although we cannot exclude the possibility that wortmannin may affect protein synthesis of IL-6 and/or IL-13, it is clear that Akt activation dose not contribute to at least kinetics of IL-6/IL-13 gene expression in the monomeric IgE-stimulated FFF mutant cells. We conclude that ERK1/2 and/or PKCs are candidates involved in common pathways for IL-6/IL-13 gene transcription because phosphorylation of these kinases was specifically delayed in the FFF mutant cells (Fig. 6F) . Since induction of b-hexosaminidase release and IL-6 production showed almost the same kinetics in the YYY wild-type and the FYF mutant cells upon monomeric IgEs stimulation (in preparation to be submitted elsewhere), we speculate that delayed mast cell activation may be caused by abrogation of phosphorylation on non-canonical and canonical tyrosine residues in the b-chain ITAM. Currently, the signaling pathways of the mutated b-chain ITAM to these kinases are not clarified. However, previous studies revealed that inflammatory cytokine production in response to the monomeric IgE entirely depends on FceRI c-chain (13) or Syk activation (13, 17) , which are downstream events of the b-chain ITAM. Thus, b-chain ITAM is likely to affect kinetics and/or strength of these proximal signaling pathways.
For future study, we are focusing on how kinetics of signaling pathways are regulated through the function of b-chain ITAM, and will examine changes of co-localization of proximal signaling molecules and the b-chain in the lipid raft of the transfectants in response to the monomeric IgEs. We believe that our findings in this study will give useful informations for elucidation of FceRI signaling. ) were stimulated with 10 lg ml ÿ1 of SPE7 with/without pre-treatment of 0.5 lM wortmannin. After 180 min, the supernatants were collected and evaluated for IL-6 and IL-13 production by specific ELISA. Cytokine production was expressed as percentage of the maximal production of each non-treated transfectant. Data shown are the mean 6 SD of triplicate samples from two independent experiments. Statistical analyses were performed by Student's t-test. *P < 0.01 relative to maximum production of each non-treated transfectant. Cells (1 3 10 6 ml ÿ1 ) were stimulated with 10 lg ml ÿ1 of SPE7 for indicated time periods and lysed. Whole proteins were analyzed by immunoblotting with phospho-specific antibodies to Akt (B), ERK1/2 and JNK1/2 (C), SHIP-1 (D) and pan-PKC (E). ERK1/2, JNK1/2 or Akt (each bottom panel) were used as loading controls of protein. One of representative of three independent experiments is demonstrated. (F) Graphs for densitometric analyses of ERK, JNK and PKCs activation are displayed. SHIP SH2 domain containing inositol 59-phosphatase TNF tumor necrosis factor TNP trinitrophenol
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